Victoria Socha

DocwireNews

NKF 2021 Spring Clinical MeetingsThe pandemic of COVID-19 has had a negative impact on various organ systems and on individuals of all ages. Kidney involvement in patients with <a href="https://www.docwirenews.com/vte-knowledge-hub/vte-knowledge-hub-picks/vte-incidence-higher-among-covid-19-patients-with-respiratory-failure/">COVID-19</a> typically manifested as acute kidney injury (AKI). However, there are few consensus data on the epidemiology of AKI in COVID-19. Ronith Chakraborty and colleagues conducted a systematic literature review to assess the knowledge gapResults of the review were reported during a virtual poster session at the NKF Spring Clinical Meetings 2021 in a <a href="https://casehippo.com/spa/symposium/national-kidney-foundation-2021-spring-clinical-meetings/event/gallery/abstracts?abstractId=2156">poster</a> titled A Systematic Review of the Incidence and Outcomes of Acute Kidney Injury in COVID-19.The researchers systematically searched Medline and Cochrane Library for literature related to AKI in COVID-19 in patients of all ages. In addition, MEDRxIV was searched for relevant unpublished manuscripts. The literature was independently assessed by two reviewers. Relevant studies assessed the incidence of AKI and the association with mortality, extracting the need for kidney replacement therapy (KRT).The review included 60 studies, representing 43,871 patients. The pooled incidence of AKI among patients with COVID-19 was 19.45% (95% confidence interval [CI], 14.63% to 24.77%); the pooled incidence of COVID-19 patients with AKI who required KRT was 39.04% (95% CI, 16.38% to 64.57%). The pooled proportion of COVID-19 positive patients was significantly lower at 8.83% (95% CI, 5.64% to 12.66%).The overall mortality of patients with COVID-19 was calculated as 17.71% (95% CI, 11.49% to 24.93%). Mortality among patients with COVID-19-related AKI was 54.24% (95% CI, 44.70% to 63.63%).In conclusion, the researchers said, &ldquo;This review found significantly higher incidence and mortality rates in COVID-19 patients with AKI, especially those requiring KRT. This suggests that kidney involvement during COVID-19 is substantial, requiring additional studies to explore KRT treatments.&rdquo;Source: Chakraborty R, Mahajan Z, Vasistha P, et al. A systematic review of the incidence and outcomes of acute kidney injury in COVID-19. Abstract of a poster presented at the National Kidney Foundation virtual Spring Clinical Meetings 2021 (Poster #6), April 9, 2021.

Jordana Jampel

FDA Approves Novel Blood Test for Alzheimer’s Detection

Dementia

Andrew Moreno

Is Plasma Mannose-Binding Lectin a Clue to Higher VTE Risk?

Katie Kosko

EMBER-3: Imlunestrant Plus Abemaciclib Improves PFS in ER+ Breast Cancer

HR Breast Cancer

Latest News

AKI in COVID-19: Incidence and Outcomes

Acute Kidney Injury

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe